Maci 3CM x 5CM implant sheets
Ended Awarded
- Contract number
- SPE2DB25FZX37
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $61,903
Award facts
- Contract value 100% obligated
- $61,902.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $61,902.91 by the Defense Logistics Agency (DLA) on July 11, 2025, for MACI 3cm x 5cm implant sheets. The delivery order, which carries an ultimate completion date of August 1, 2025, was issued without a set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499,999,999 single-award contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide.
The MACI implants are specialized regenerative medicine products used in orthopedic procedures to support cartilage repair and restoration. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its established relationship with the DLA to distribute branded and generic prescription drugs, biologics, and medical consumables directly to military health facilities. The firm's consistent performance across multiple delivery orders demonstrates its capability to meet the specialized pharmaceutical procurement requirements of the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DB25FZX37?
SPE2DB25FZX37 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 11, 2025.
How much is contract SPE2DB25FZX37 worth?
The government has obligated $61,903 on SPE2DB25FZX37.
Is contract SPE2DB25FZX37 an order under another contract?
Yes. SPE2DB25FZX37 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX37 competed?
The extent of competition for SPE2DB25FZX37 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award